Many people don’t know they have cardiovascular disease until they end up in the hospital with myocardial infarction. But a few strange external signs could signal all is not right with the heart, an anatomy professor noted in The New Zealand Times.

New research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 suggests individuals with depression may have an increased risk of developing atrial fibrillation (AFib).

Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to include a new indication in the Repatha® (evolocumab) label for adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering LDL-C levels.

Occluder devices to combat congenital structural heart defects designed by the indigenous Aymara women suggest “excellent” clinical outcomes and have been approved by regulatory agencies in Canada, South America and the European Union.

New research out of Japan shows eating slowly may positively affect changes in obesity, BMI and waist circumference.

St. Joseph Mercy Oakland in Pontiac, Michigan, is the first hospital certified by the Joint Commission as a thrombectomy-capable stroke center (TSC), according to a March 21 press release.

Edwards Lifesciences Corporation today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve.

It’s not just the meat you eat that impacts your risk of developing high blood pressure—but how you cook it, according to research presented March 21 at the American Heart Association’s Epidemiology and Prevention/Lifestyle and Cardiometabolic Health scientific sessions in New Orleans.